Complete response of metastatic cutaneous squamous cell carcinoma and multiple locally advanced basal cell carcinomas with concomitant pembrolizumab and sonidegib therapy

Other authors

Institut Català de la Salut

[González-Cruz C, García-Patos V, Ferrándiz-Pulido C] Servei de Dermatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Facultat de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Muñoz-Couselo E, Ortiz-Velez C] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona Spain. Vall d’Hebron Institute of Oncology (VHIO), Biblioteca, Spain. [Ferrer B] Servei d’Anatomia Patològica, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2024-04-11T08:00:05Z

2024-04-11T08:00:05Z

2024-03-01



Abstract

Basal cell carcinoma; Immunomodulatory therapy; Squamous cell carcinoma


Carcinoma basocelular; Terapia inmunomoduladora; Carcinoma de células escamosas


Carcinoma basocel·lular; Teràpia immunomoduladora; Carcinoma de cèl·lules escamoses


Supported by a grant from Sun Pharma. The funders had no role in the design and conduct of the study, collection, management, analysis, and interpretation of the data, preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.

Document Type

Article


Published version

Language

English

Publisher

Elsevier

Related items

JAAD Case Reports;46

https://doi.org/10.1016/j.jdcr.2024.02.011

Recommended citation

This citation was generated automatically.

Rights

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

This item appears in the following Collection(s)